Dynavax Technologies (DVAX)
12.95 x 44 12.96 x 116
Post-market by (Cboe BZX)
12.97 -0.71 (-5.19%) 03/31/25 [NASDAQ]
12.95 x 44 12.96 x 116
Post-market 12.97 unch (unch) 16:36 ET
for Mon, Mar 31st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | 27,309 | 20,259 | 2,665 | -8,721 | -6,389 |
Depreciation Amortization | -6,493 | -5,911 | -4,538 | -2,580 | -9,279 |
Accounts receivable | -2,373 | -30,744 | -18,097 | -1,621 | 43,268 |
Accounts payable and accrued liabilities | 3,899 | 2,023 | -569 | -2,640 | 1,952 |
Other Working Capital | -16,037 | -48,763 | -37,228 | -26,116 | 61,206 |
Other Operating Activity | 60,207 | 76,637 | 51,801 | 24,999 | 9,805 |
Operating Cash Flow | $66,512 | $13,501 | $-5,966 | $-16,679 | $100,563 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -11,683 | -38,527 | -24,408 | 3,580 | -150,824 |
PPE Investments | -6,352 | -2,874 | -1,528 | -749 | -3,104 |
Investing Cash Flow | $-18,035 | $-41,401 | $-25,936 | $2,831 | $-153,928 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 7,289 | 5,685 | 2,958 | 2,539 | 7,895 |
Common Stock Repurchased | -100,000 | N/A | N/A | N/A | N/A |
Other Financing Activity | -9,306 | -8,827 | -8,576 | -6,742 | -6,509 |
Financing Cash Flow | $-102,017 | $-3,142 | $-5,618 | $-4,203 | $1,386 |
Exchange Rate Effect | -862 | 98 | -265 | -201 | 324 |
Beginning Cash Position | 150,556 | 150,556 | 150,556 | 150,556 | 202,211 |
End Cash Position | 96,154 | 119,612 | 112,771 | 132,304 | 150,556 |
Net Cash Flow | $-54,402 | $-30,944 | $-37,785 | $-18,252 | $-51,655 |
Free Cash Flow | |||||
Operating Cash Flow | 66,512 | 13,501 | -5,966 | -16,679 | 100,563 |
Capital Expenditure | -6,352 | -2,874 | -1,528 | -749 | -4,104 |
Free Cash Flow | 60,160 | 10,627 | -7,494 | -17,428 | 96,459 |